FindTrial
Sign In

Probiotic Agent

DRUG8 trials

Sponsors

Shandong University, Capital Medical University, Peking Union Medical College Hospital, Ziauddin University, Rush University Medical Center

Conditions

Epilepsies RefractoryGERDImmune SurveillanceImmune ThrombocytopeniaPeriodontitis Stage IIIPolycystic Ovary SyndromePost-Acute COVID-19 SyndromeProbiotic

Phase 2

Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
NCT03033199
Shandong UniversityImmune Thrombocytopenia
Start: 2017-01-31End: 2018-08-31Target: 60Updated: 2017-01-26
Probiotic Use for Recovery Enhancement From Long COVID-19
CompletedNCT06643299
Rush University Medical CenterPost-Acute COVID-19 Syndrome
Start: 2025-05-13End: 2026-07-02Updated: 2026-08-07

Phase 3

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
NCT03843736
Peking Union Medical College HospitalPolycystic Ovary Syndrome
Start: 2019-02-21End: 2020-12-31Target: 200Updated: 2019-10-10

Unknown Phase

A New System for GERD Diagnosis and Treatment
NCT03600974
Capital Medical UniversityGERD
Start: 2019-02-01End: 2021-07-01Target: 200Updated: 2019-02-05
Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS
CompletedNCT04009603
Ziauddin UniversityPolycystic Ovary Syndrome
Start: 2018-12-06End: 2020-01-28Updated: 2020-07-07
Acute Immune Modulation by Probiotic Strain
CompletedNCT06754228
Natural Immune Systems IncImmune Surveillance
Start: 2024-11-13End: 2025-12-23Updated: 2026-08-17
Evaluation of the Effect of Streptococcus Salivarius K12 Probiotic in the Treatment of Periodontitis
CompletedNCT06871540
AYŞENUR ŞAHİNPeriodontitis Stage III, Probiotic
Start: 2023-10-01End: 2024-06-30Updated: 2025-03-12
Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
Active, not recruitingNCT07100743
National University of MalaysiaEpilepsies Refractory
Start: 2023-04-03End: 2026-03-02Updated: 2025-08-03